BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s stock price reached a new 52-week high on Wednesday . The stock traded as high as $1.36 and last traded at $1.27, with a volume of 74859 shares traded. The stock had previously closed at $1.34.
BioRestorative Therapies Trading Down 5.2 %
The company has a market cap of $2.08 billion, a PE ratio of -1.25 and a beta of 102.36. The firm’s 50-day simple moving average is $1.36 and its two-hundred day simple moving average is $1.67.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Featured Articles
- Five stocks we like better than BioRestorative Therapies
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- High-Yield Texas Instruments Could Hit New Highs Soon
- Canadian Penny Stocks: Can They Make You Rich?
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- Following Congress Stock Trades
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
